PDCD1 and neoplasm: To determine if the increased efficacy from addition of PD-1 blockade to T-cell therapy was associated with increased tumor infiltration by transferred tumor-targeting T cells, the concentrations of tumor infiltrating OT-I T cells and endogenous CD8 T cells after treatment were determined (figure 1B).